Latest: FDA Approves New Biosimilar for Oncology Treatment

Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer

14 August, 2025

0 Mins

High-volume cancer centers utilizing neoadjuvant chemotherapy (NACT) significantly reduce surgical mortality and enhance survival rates in patients with advanced ovarian cancer.

Tags:

Author

American Journal Managed Care

CEPHEUS Trial Data Reinforce DVRd as New Standard for Multiple Myeloma: Saad Z. Usmani, MD, MBA

Tricuspid Regurgitation Reliable Prognostic Indicator of PAH Severity

📢

300x250 Banner

Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer

Tags:

American Journal Managed Care

CEPHEUS Trial Data Reinforce DVRd as New Standard for Multiple Myeloma: Saad Z. Usmani, MD, MBA

Tricuspid Regurgitation Reliable Prognostic Indicator of PAH Severity

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition